Libya vs Papua New Guinea: Access to anti-retroviral drugs, female
Libya
52.0%
in 2023
Papua New Guinea
51.0%
in 2024
Libya rank
116th
Papua New Guinea rank
118th
Access to anti-retroviral drugs, female over time
- Libya
- Papua New Guinea
How they compare
Libya currently reports 52.0% against 51.0% in Papua New Guinea, a difference of 1.0%.
Across all 24 years both countries report, Libya has been ahead every year.
Libya ranks 116th and Papua New Guinea ranks 118th of 141 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.2% | 3.8% | 5.4% | Libya |
| 2010s | 41.6% | 30.4% | 11.2% | Libya |
| 2020s | 50.2% | 45.0% | 5.2% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Libya or Papua New Guinea?
- Libya, at 52.0% against 51.0% in Papua New Guinea as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Libya and Papua New Guinea?
- 1.0%, with Libya ahead.
- How many years of comparable data are there for Libya and Papua New Guinea?
- 24 years are reported by both, from 2000 to 2023.
- How do Libya and Papua New Guinea rank globally for access to anti-retroviral drugs, female?
- Libya ranks 116th and Papua New Guinea ranks 118th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.